Open ADAMTS13 Appears to Have Diagnostic Value in Immune Thrombotic Thrombocytopenic Purpura
Researchers sought to determine whether ADAMTS13 with an open confirmation would impact diagnosis in patients with iTTP.
Researchers sought to determine whether ADAMTS13 with an open confirmation would impact diagnosis in patients with iTTP.
Researchers sought to determine whether MRI could show evidence of brain infarction in patients with iTTP.
Researchers sought to identify genes related to complement dysfunction in patients with iTTP.
Researchers sought to determine whether azathioprine should be evaluated as an option for second-line therapy in patients with of immune-related TTP.
Researchers sought to determine whether an assay using flow cytometry may help to diagnose patients who have vaccine-induced immune thrombotic thrombocytopenia.
Researchers sought to determine whether rilzabrutinib would be effective in treating immune thrombocytopenia.
The phase 3 ADVANCE trial evaluated the efficacy and safety of efgartigimod in 131 adults with primary ITP.
Researchers sought to determine the cost-effectiveness of eltrombopag for patients with immune thrombocytopenia compared with intravenous immunoglobulin.
Researchers sought to describe a case of vaccine-induced immune thrombotic thrombocytopenia in a patient after an adenovirus vector-based COVID-19 vaccine.
Researchers sought to determine the pathology behind possible vaccine-induced immune thrombocytopenia and thrombosis following COVID-19 vaccinations.